Chwatowa A W, Weinstein E S, Dimitrowskaja I P, Izikson L J, Burdjanskaja E I, Sorokina M N, Timakowa W I
Klin Monbl Augenheilkd. 1980 May;176(5):758-63. doi: 10.1055/s-2008-1057549.
Immediate and late results of treatment in 132 cases with bilateral retinoblastoma (the children were aged between two months and six years) were analyzed. Combined treatment comprised enucleation of the more affected eye, further chemotherapy, X-ray treatment and photocoagulation. Cytostatic compounds used were "TET" (analogous to "TEM") and "Prospidin". Of the treated children, 44.8% are alive; the period of observation ranged from seven to 16 years.
对132例双侧视网膜母细胞瘤患儿（年龄在2个月至6岁之间）的治疗近期和远期结果进行了分析。综合治疗包括摘除病情较重的一侧眼球，进一步化疗、X线治疗和光凝治疗。使用的细胞抑制剂为“TET”（类似于“TEM”）和“丙亚胺”。接受治疗的患儿中，44.8%存活；观察期为7至16年。
